Detalhe da pesquisa
1.
Challenges associated with the integration of immuno-oncology agents in clinical practice.
BMC Med Educ
; 22(1): 781, 2022 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36371179
2.
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer.
N Engl J Med
; 373(17): 1627-39, 2015 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-26412456
3.
Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study.
Lancet Oncol
; 18(1): 31-41, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27932067
4.
Ascertainment, classification, and impact of neoplasm detection during prolonged treatment with dual antiplatelet therapy with prasugrel vs. clopidogrel following acute coronary syndrome.
Eur Heart J
; 37(4): 412-22, 2016 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-26637834
5.
Genetic variants in ABCG1 are associated with survival of nonsmall-cell lung cancer patients.
Int J Cancer
; 138(11): 2592-601, 2016 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26757251
6.
Smoking history predicts for increased risk of second primary lung cancer: a comprehensive analysis.
Cancer
; 121(4): 598-604, 2015 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25283893
7.
Patient-Reported Distress and Clinical Outcomes with Immuno-Oncology Agents in Metastatic Non-Small Cell Lung Cancer (mNSCLC): A Real-World Retrospective Cohort Study.
Lung Cancer
; 175: 17-26, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36442383
8.
First-line nivolumab plus ipilimumab for metastatic non-small cell lung cancer, including patients with ECOG performance status 2 and other special populations: CheckMate 817.
J Immunother Cancer
; 11(2)2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36725084
9.
A Phase 2 Clinical Trial of Combination Nivolumab, Ipilimumab, and Paclitaxel in Patients With Untreated Metastatic NSCLC: The OPTIMAL Trial.
JTO Clin Res Rep
; 3(6): 100337, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35719867
10.
Perioperative outcomes of pulmonary resection after neoadjuvant pembrolizumab in patients with non-small cell lung cancer.
J Thorac Cardiovasc Surg
; 163(2): 427-436, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33985811
11.
Predictive Value of Combining Biomarkers for Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.
Clin Lung Cancer
; 22(6): 500-509, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33972172
12.
Synergy between early-incorporation immunotherapy and extracranial radiotherapy in metastatic non-small cell lung cancer.
Transl Lung Cancer Res
; 10(1): 261-273, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33569310
13.
The immunotherapeutic landscape in non-small cell lung cancer and its surgical horizons.
J Thorac Cardiovasc Surg
; 159(4): 1616-1623, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-31836182
14.
Definitive Radiotherapy for Inoperable Stage IIB Non-small-cell Lung Cancer: Patterns of Care and Comparative Effectiveness.
Clin Lung Cancer
; 21(3): 238-246, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31757764
15.
Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort.
J Thorac Oncol
; 15(3): 426-435, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31629915
16.
Therapeutic outcomes in non-small cell lung cancer with BRAF mutations: a single institution, retrospective cohort study.
Transl Lung Cancer Res
; 8(3): 258-267, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31367539
17.
Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1-Low/Negative Recurrent or Metastatic HNSCC: The Phase 2 CONDOR Randomized Clinical Trial.
JAMA Oncol
; 5(2): 195-203, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30383184
18.
Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy.
Eur J Cancer
; 107: 142-152, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30576970
19.
Phase I study of the farnesyltransferase inhibitor lonafarnib with weekly paclitaxel in patients with solid tumors.
Clin Cancer Res
; 13(2 Pt 1): 576-83, 2007 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17255280
20.
Long-term survival follow-up of atezolizumab in combination with platinum-based doublet chemotherapy in patients with advanced non-small-cell lung cancer.
Eur J Cancer
; 101: 114-122, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30053670